Results 231 to 240 of about 1,794,315 (321)

Part III: Clinical Departments and Divisions --- Chapter 10: Division of Hematology (pages 284-297) [PDF]

, 1989

core   +1 more source

Haemoglobin genotypes in cod (Gadus morhua L): their geographic distribution and physiological significance [PDF]

, 2013
Behrens, Jane W., Brander, Keith, Methling, Caroline, Mork, Jarle, Ross, Stine Dalmann   +4 more
core   +1 more source

Catalytic Amyloids: Turning Fibrils Into Biocatalysts

Chemistry – A European Journal, EarlyView.
Amyloids, traditionally associated with diseases, have emerged as versatile catalytic scaffolds. From natural amyloid sequences to bioinspired and de novo designs, we highlight strategies to construct catalytic active sites and anchor enzymes onto fibrils, creating versatile nanomaterials with tunable activities. ABSTRACT Amyloids have been regarded as
Alessandra Esposito, Linda Leone, Flavia Nastri, Angela Lombardi   +3 more
wiley   +1 more source

Population Pharmacokinetics and Exposure–Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis

Clinical Pharmacology &Therapeutics, EarlyView.
Momelotinib, a Janus kinase (JAK) 1/JAK2/activin A receptor type 1 inhibitor, is approved for the treatment of myelofibrosis with anemia. These analyses characterized the population pharmacokinetics of momelotinib and its active metabolite M21 following administration of the commercial tablet formulation in patients with myelofibrosis from phase II/III
Benjamin Rich, Meenakshi Srinivasan, Yu Liu Ho, Sandra A.G. Visser, Geraldine Ferron‐Brady, Georgios Vlasakakis   +5 more
wiley   +1 more source

Changes in body composition and their association with erythrocyte mass in regular exercisers: A cross-sectional study. [PDF]

Medicine (Baltimore)
Demircioğlu S, Tekinalp A, Korkmaz C, Alkan Baylan F, Merter M.   +4 more
europepmc   +1 more source

Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an In Vivo Model for Controlled Induction of Vascular Leakage in Healthy Volunteers

Clinical Pharmacology &Therapeutics, EarlyView.
Vascular leakage and its associated phenomena vasodilation and endothelial activation are pathophysiological features of various diseases. Multiple drug candidates targeting these phenomena are in development, necessitating translational models to demonstrate proof‐of‐pharmacology and proof‐of‐mechanism in early‐phase clinical trials.
Marella Cornelia Elizabeth van Ruissen, Menno van Diemen, Liza Botros, Ingrid Tomljanovic, Hind Achbo, Dimitra Eleftheriou, Paul Willem Schenk, Naomi Bertine Klarenbeek, Derek William Gilroy, Manon Aleida Adriana Jansen, Matthijs Moerland   +10 more
wiley   +1 more source

Haemoglobin variants in nigeria: real-world data from a point-of-care device. [PDF]

Ann Hematol
Kotila T, Aworanti O, Akunwata C, Ogundeji P, Oresanya S, Adewale A, Alabi R, Fasola F, Olaniyi J.   +8 more
europepmc   +1 more source

Radioimmunoassay of free cortisol with antiserum-coated tubes and 125I-labelled cortisol [PDF]

, 1980
A. Boldrini, A. Clerico, C. Cipolloni, G. Mariani, M. Ferdeghini, M.G. Del Chicca   +5 more
core  

Efficacy of Oral Iron Supplementation in Anemic Pregnant Women with Normal and Abnormal Hemoglobin Typing

Wattanai Kosidapan
openalex   +1 more source

Repeated Intake of Grapefruit Juice Inhibits CYP2B6, CYP2C9, CYP2C19, and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans

Clinical Pharmacology &Therapeutics, EarlyView.
Grapefruit juice is a well‐established inhibitor of cytochrome P450 (CYP) 3A4, but its effects on other CYP enzymes or organic anion transporting polypeptides (OATPs) are not fully characterized in humans. Recently, lingonberry powder was shown to induce murine CYP enzymes. We investigated the effects of lingonberry powder and grapefruit juice on seven
Laura Aurinsalo, Outi Lapatto‐Reiniluoto, Mika Kurkela, Mikko Neuvonen, Eeva Moilanen, Mikko Niemi, Aleksi Tornio, Janne T. Backman   +7 more
wiley   +1 more source